SGRL

HealthcareDrug Manufacturers - Specialty & Generic0
Shree Ganesh Remedies Ltd
₹507.6
Previous trading day close · Data updates nightly
56/100
AverageResearch Score
Market Cap
N/A
P/E Ratio
42.19
Premium
P/B Ratio
5.96
Premium
ROE
17.3%
Decent
ROCE
14.8%
Good
Debt / Equity
0.19
Low debt
Div. Yield
N/A
EV/EBITDA
20.91
Fair
Data as of previous trading day close · Updated nightly
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated nightly
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
68/100
Growth
Revenue, EPS, profit growth
46/100
Valuation
PE, PB, EV/EBITDA vs sector
34/100
Risk
Debt levels, volatility, coverage
81/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
42.19(Premium)
Forward P/E
N/A
P/B Ratio
5.96(Premium)
P/S Ratio
7.70(Expensive)
EV/EBITDA
20.91(Expensive)
Dividend Yield
N/A
5Y CAGR
16.1%(High growth)
Revenue Growth
-41.8%(Moderate)
Profitability
ROE
17.3%(Good)
ROCE
14.8%(Good)
ROA
12.7%(Efficient)
Net Margin
15.6%(High)
EBITDA Margin
34.8%
Financial Health
Debt to Equity
0.19(Low debt)
Current Ratio
4.79(Healthy)
Quick Ratio
3.43(Good)
Interest Coverage
7.74x(Comfortable)
Technical Indicators
Based on previous trading day close
Volume
6.2K
Shareholding Pattern
Promoter
72.8%
High confidence
FII
0.0%
DII / MF
0.0%
Share SGRL
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates nightly after market close. Please consult a SEBI-registered advisor before investing.
SGRL Share Price - ₹507.60 | Research Score & Analysis | StockSage Pro